INNV Stock Overview
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities.
No risks detected for INNV from our risk checks.
InnovAge Holding Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$4.08|
|52 Week High||US$15.89|
|52 Week Low||US$3.46|
|1 Month Change||-13.56%|
|3 Month Change||-9.13%|
|1 Year Change||-72.67%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-83.14%|
Recent News & Updates
InnovAge names Richard Feifer as chief medical officer
InnovAge (NASDAQ:INNV) on Wednesday named Richard Feifer as its chief medical officer (CMO). As CMO, Feifer will lead the company's clinical care delivery, including medical care, quality, pharmacy, dental, and behavioral health, INNV said in a statement. INNV provides healthcare programs for senior citizens through its Program of All-inclusive Care for the Elderly. Feifer was most recently at Genesis HealthCare, which runs more 250 nursing centers and senior living communities. INNV stock earlier closed -6.2% at $4.08.
InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...
|INNV||US Healthcare||US Market|
Return vs Industry: INNV underperformed the US Healthcare industry which returned 13% over the past year.
Return vs Market: INNV underperformed the US Market which returned -8.9% over the past year.
|INNV Average Weekly Movement||11.1%|
|Healthcare Industry Average Movement||8.7%|
|Market Average Movement||7.6%|
|10% most volatile stocks in US Market||17.0%|
|10% least volatile stocks in US Market||3.1%|
Stable Share Price: INNV is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: INNV's weekly volatility (11%) has been stable over the past year.
About the Company
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
InnovAge Holding Fundamentals Summary
|INNV fundamental statistics|
Is INNV overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|INNV income statement (TTM)|
|Cost of Revenue||US$168.22m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.093|
|Net Profit Margin||1.82%|
How did INNV perform over the long term?See historical performance and comparison
Is INNV undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for INNV?
Other financial metrics that can be useful for relative valuation.
|What is INNV's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does INNV's PE Ratio compare to its peers?
|INNV PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
NRC National Research
CO Global Cord Blood
INNV InnovAge Holding
Price-To-Earnings vs Peers: INNV is expensive based on its Price-To-Earnings Ratio (43.7x) compared to the peer average (14.3x).
Price to Earnings Ratio vs Industry
How does INNV's PE Ratio compare vs other companies in the US Healthcare Industry?
Price-To-Earnings vs Industry: INNV is expensive based on its Price-To-Earnings Ratio (43.7x) compared to the US Healthcare industry average (19.7x)
Price to Earnings Ratio vs Fair Ratio
What is INNV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||43.7x|
|Fair PE Ratio||168.1x|
Price-To-Earnings vs Fair Ratio: INNV is good value based on its Price-To-Earnings Ratio (43.7x) compared to the estimated Fair Price-To-Earnings Ratio (168.1x).
Share Price vs Fair Value
What is the Fair Price of INNV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: INNV ($4.08) is trading below our estimate of fair value ($8.24)
Significantly Below Fair Value: INNV is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
How is InnovAge Holding forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Future Growth Score4/6
Future Growth Score 4/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: INNV's forecast earnings growth (84.2% per year) is above the savings rate (1.9%).
Earnings vs Market: INNV's earnings (84.2% per year) are forecast to grow faster than the US market (14.5% per year).
High Growth Earnings: INNV's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: INNV's revenue (15.8% per year) is forecast to grow faster than the US market (7.9% per year).
High Growth Revenue: INNV's revenue (15.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: INNV's Return on Equity is forecast to be low in 3 years time (11.5%).
Discover growth companies
How has InnovAge Holding performed over the past 5 years?
Past Performance Score3/6
Past Performance Score 3/6
Growing Profit Margin
Earnings vs Industry
Last years revenue growth
Earnings and Revenue History
Quality Earnings: INNV has high quality earnings.
Growing Profit Margin: INNV became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: INNV has become profitable over the past 5 years.
Accelerating Growth: INNV has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: INNV has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (8.1%).
Return on Equity
High ROE: INNV's Return on Equity (3.2%) is considered low.
Discover strong past performing companies
How is InnovAge Holding's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: INNV's short term assets ($250.4M) exceed its short term liabilities ($94.4M).
Long Term Liabilities: INNV's short term assets ($250.4M) exceed its long term liabilities ($97.7M).
Debt to Equity History and Analysis
Debt Level: INNV has more cash than its total debt.
Reducing Debt: Insufficient data to determine if INNV's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: INNV's debt is well covered by operating cash flow (46%).
Interest Coverage: INNV's interest payments on its debt are well covered by EBIT (11.2x coverage).
Discover healthy companies
What is InnovAge Holding current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate INNV's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate INNV's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if INNV's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if INNV's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as INNV has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Patrick Blair (51 yo)
Mr. Patrick Blair serves as President of InnovAge Holding Corp. since December 1, 2021 and as its CEO since January 01, 2022. He had been the Chief Marketing Officer and Senior Vice President of Commercial...
Experienced Management: INNV's management team is not considered experienced ( 2 years average tenure), which suggests a new team.
Experienced Board: INNV's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
InnovAge Holding Corp.'s employee growth, exchange listings and data sources
- Name: InnovAge Holding Corp.
- Ticker: INNV
- Exchange: NasdaqGS
- Founded: 2007
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$552.942m
- Shares outstanding: 135.53m
- Website: https://www.innovage.com
Number of Employees
- InnovAge Holding Corp.
- 8950 East Lowry Boulevard
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/17 00:00|
|End of Day Share Price||2022/08/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.